Vanda Pharmaceuticals reported $0 in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Agios Pharmaceuticals AGIO:US $ 0M 0.17M
Akebia Therapeutics AKBA:US $ 97.23M 0.31M
Alnylam Pharmaceuticals ALNY:US $ 433.8M 0.65M
Anika Therapeutics ANIK:US $ 0M 0M
Arena Pharmaceuticals ARNA:US $ 37.48M 1.3M
Arrowhead Research ARWR:US $ 0 0
AstraZeneca AZN:LN 28939M 4338M
Bluebird Bio BLUE:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 39677M 2826M
Clovis Oncology CLVS:US $ 599.54M 16.41M
Eli Lilly And LLY:US $ 15522.4M 785.8M
Esperion Therapeutics ESPR:US $ 272.51M 410K
Halozyme Therapeutics HALO:US $ 786.45M 0.88M
Insmed INSM:US $ 571.41M 8.55M
Ligand Pharmaceuticals LGND:US $ 316.89M 1.57M
Minerva Neurosciences NERV:US $ 0M 0M
Moderna Inc MRNA:US $ 238M 90M
Novartis NVS:US $ 24715M 1776M
Ptc Therapeutics PTCT:US $ 972.21M 143.17M
Puma Biotechnology PBYI:US $ 96.8M 28.1M
Sangamo Biosciences SGMO:US $ 0M 0M
Takeda 4502:JP Y 4016473M 365116M
Teva Pharmaceutical TEVA:IT 21.04B 565M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Veracyte VCYT:US $ 1.08M 0.16M